Skip to main content
Clinical Trials/CTRI/2020/11/029184
CTRI/2020/11/029184
Completed
未知

Comparison of Efficacy and Cognitive Side Effect Profile Between Right Unilateral and Bilateral Ultra Brief Pulse ECT and Serum BDNF as Biomarker of Response in Schizophrenia: A Case Control Study

Dr Sukriti Mukherjee0 sites60 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: F20- Schizophrenia
Sponsor
Dr Sukriti Mukherjee
Enrollment
60
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
October 8, 2021
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Sukriti Mukherjee

Eligibility Criteria

Inclusion Criteria

  • i)Patients of either Sex aged between 18\-60 years.
  • ii)Right handed patients as assessed by Sidedness Bias Schedule (Mandal et al., 1992\)
  • iii)Diagnosis of Schizophrenia (F20\.0 to F20\.9\) according to ICD 10, having clinical indication for Electroconvulsive therapy.
  • iv)Patients giving written informed Consent.

Exclusion Criteria

  • i)Patients having predominant Catatonic symptoms
  • ii)Any other Psychiatric comorbidity
  • iii)Significant Neurological or Medical illness
  • iv)Female patients who are Pregnant during the study period.
  • v)Patients using any psychoactive substances in dependence pattern. (Except Caffeine and Nicotine)
  • vi)Patients on Clozapine

Outcomes

Primary Outcomes

Not specified

Similar Trials